# Characteristics and Prognosis of Early‐Onset vs. Late‐Onset Colon Cancer: A Propensity Score Matching Analysis Based on Histology

**Authors:** Xiaobin Cheng, Tao Xiang, Saisai Wang, Jinhai Wang

PMC · DOI: 10.1002/cam4.71681 · Cancer Medicine · 2026-03-03

## TL;DR

This study compares the prognosis of early-onset and late-onset colon cancer, showing that age and histology together influence survival outcomes.

## Contribution

The study introduces a novel approach combining age at diagnosis and histology to assess colon cancer prognosis.

## Key findings

- Early-onset adenocarcinoma had the best cancer-specific and surgery-specific survival.
- Late-onset mucinous adenocarcinoma showed the worst survival outcomes.
- Nonmetastatic early-onset adenocarcinoma had poorer surgery-specific survival than late-onset adenocarcinoma.

## Abstract

The prognostic value of age at diagnosis in colon cancer is poorly understood. This study evaluated the influence of age at diagnosis and histologic subtype on colon cancer prognosis using data from 180,804 patients in the SEER database.

Patients were stratified into early‐onset and late‐onset groups and by histology—adenocarcinoma or mucinous adenocarcinoma. Early‐onset colon cancer was associated with more advanced tumor stages. Propensity score matching balanced cohorts for Kaplan–Meier and Cox regression analyses of cancer‐specific survival (CSS) and surgery‐specific survival (SSS).

Survival analyses revealed that patients with early‐onset adenocarcinoma had the most favorable CSS and SSS, whereas those with late‐onset mucinous adenocarcinoma experienced the worst outcomes; no significant age‐related differences emerged histology‐stratified. Importantly, among nonmetastatic patients, early‐onset adenocarcinoma showed significantly poorer SSS compared to late‐onset adenocarcinoma.

These findings emphasize the necessity of integrating age and histologic type for accurate prognostic assessment and personalized treatment strategies in colon cancer.

## Linked entities

- **Diseases:** colon cancer (MONDO:0002032)

## Full-text entities

- **Genes:** KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}, APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, AMER1 (APC membrane recruitment protein 1) [NCBI Gene 139285] {aka FAM123B, OSCS, WTX}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}
- **Diseases:** stage IV disease (MESH:D007676), EOMC (MESH:D002288), toxicity (MESH:D064420), metastasis (MESH:D009362), Colon cancer (MESH:D015179), SSS (MESH:D011475), death (MESH:D003643), colon excluding (MESH:D003108), Cancer (MESH:D009369), EOAC (MESH:D000230), Rectal cancer (MESH:D012004), disease (MESH:D004194), hereditary cancer syndromes (MESH:D009386), colon adenocarcinoma (MESH:D003110)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956548/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956548/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956548/full.md

---
Source: https://tomesphere.com/paper/PMC12956548